Rhinovirus: Major agent for upper respiratory tract infections;Rhinovirus: Principal agent des infections des voies aériennes supérieures

Virologie

Volumn 8, Issue 4, 2004, Pages 271-280

  Billaud, G ^a   Lina, B ^a  

^a HOSPICES CIVILS DE LYON   (France)

Author keywords

Antiviral; Diagnosis; Epidemiology; Rhinovirus

Indexed keywords

AIRBORNE INFECTION; ASTHMA; COMMON COLD; PHYLOGENY; PICORNAVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHINOVIRUS; TISSUE CULTURE; UPPER RESPIRATORY TRACT INFECTION;

PICORNAVIRIDAE; RHINOVIRUS;

EID: 4644364691     PISSN: 12678694     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Makela MJ, Puhakka T, Ruuskanen O, et al. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol 1998; 36: 539-42.
2. Uncapher CR, DeWitt CM, Colonno RJ. The major and minor group receptor families contain all but one human rhinovirus serotype. Virology 1991; 180: 814-7.
3. King AMQ, Brown F, Christian P, et al. Family Picornaviridae. In: van Regenmortel MHV, Bishop DHL, Carstens EB, et al., Virus taxonomy: classification and nomenclature of viruses. 7th report of the International Committee for the Taxonomy of Viruses. Academic Press, San Diego, USA.
4. Rueckert R. Picornaviridae: the viruses and their replication. In: Fields BN editor, Fields Virology. Philadelphia, PA: Lippincott-Raven; 1996.
5. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. Br Med J 1995; 310: 1225-9.
6. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. Br Med J 1993; 307: 982-6.
7. Monto AS. The seasonality of rhinovirus infections and its implications for clinical recognition. Clin Ther 2002; 24: 1987-97.
8. Arruda E, Hayden FG. Detection of human rhinovirus RNA in nasal washings by PCR. Mol Cell Probes 1993; 7: 373-9.
9. Billaud G, Peny S, Legay V, Lina B, Valette M. Detection of rhinovirus and enterovirus in upper respiratory tract samples using a multiplex nested PCR. J Virol Methods 2003; 108: 223-8.
10. Turner RB, Wecker MT, Pohl G, et al. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. JAMA 1999; 281: 1797-804.
11. Hayden FG, Turner RB, Gwaltney JM, et al. Phase II, randomized, double-blind, placebo-controlled studies of Ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced Rhinovirus colds in healthy volunteers. Antimicrobial Agents Chemother 2003; 47: 3907-16.
12. Hsyu PH, Pithavala YK, Gersten M, Penning CA, Kerr BM. Pharmacokinetics and safety of an antirhinoviral agent, ruprintrivir, in healthy volunteers. Antimicrobial Agents Chemother 2002; 46: 392-7.
13. Tomassini JE, Graham D, DeWitt CM, Lineberger DW, Rodkey JA, Colonno RJ. cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1989; 86: 4907-11.
14. Hofer F, Gruenberger M, Kowalski H, et al. Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc Natl Acad Sci USA 1994; 91: 1839-42.
15. Blomqvist S, Savolainen C, Raman L, Roivainen M, Hovi T. Human rhinovirus 87 and enterovirus 68 represent a unique serotype with rhinovirus and enterovirus features. J Clin Microbiol 2002; 40: 4218-23.
16. Bella J, Kolatkar PR, Marlor CW, Greve JM, Rossmann MG. The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand. Proc Natl Acad Sci USA 1998; 95: 4140-5.
17. Snyers L, Zwickl H, Blaas D. Human rhinovirus type 2 is internalized by clathrin-mediated endocytosis. J Virol 2003; 77: 5360-9.
18. DeTulleo L, Kirchhausen T. The clathrin endocytic pathway in viral infection. EMBO J 1998; 17: 4585-93.
19. Brabec M, Baravalle G, Blaas D, Fuchs R. Conformational changes, plasma membrane penetration, and infection by human rhinovirus type 2: role of receptors and low pH. J Virol 2003; 77: 5370-7.
20. Monto AS. Epidemiology of viral respiratory infections. Am J Med 2002; 112(Suppl. 6A): 45-125.
21. Hendley JO, Gwaltney Jr JM. Mechanisms of transmission of rhinovirus infections. Epidemiol Rev 1988; 10: 243-58.
22. th ed. Alfred S, Evans AS, Kaslow RA editors, Viral infections of humans: epidemiology and control. New York: Plenum Press, 1997.
23. Gwaltney JM, Hendley JO. Rhinovirus transmission: one ifby air, two ifby hand. Am J Epidemiol 1978; 107: 357-61.
24. Goldmann DA. Tansmission of viral respiratory infections in the home. Pediatr Infect Dis J 2000; (10 Suppl): S97-102.
25. Monto AS, Ullman BM. Acute respiratory illness in an American community. JAMA 1974; 227: 164-9 The Tecumseh study.
26. Arruda E, Pitkaranta A, Witek Jr TJ, Doyle CA, Hayden FG. Frequency and natural history of rhinovirus infections in adults during autumn. J Clin Microbiol 1997; 35: 2864-8.
27. Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect 1993; 110: 145-60.
28. Gwaltney JM. Clinical significance and pathogenesis of viral respiratory infections. Am J Med 2002; 112: 13S-18S.
29. Douglas RG, Cate TR, Gerone PJ, Couch RB. Quantitative rhinovirus shedding patterns in volunteers. Am Rev Respir Dis 1966; 94: 159-67.
30. Harris 2nd JM, Gwaltney JM. Incubation periods of experimental rhinovirus infection and illness. Clin Infect Dis 1996; 23: 1287-90.
31. Couch RB. Rhinoviruses. In: Fields BN editor, Fields virology. Philadelphia, PA: Lippincott-Raven; 1996.
32. Guittet V, Brouard J, Vabret A, et al. Rhinovirus and acute respiratory infections in hospitalized children. Arch Pediatr 2003; 10: 417-23 Retrospective study 1998-2000.
33. Pitkaranta A, Virolainen A, Jero J, Arruda E, Hayden FG. Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction. Pediatrics 1998; 102(2 Pt 1): 291-5.
34. Greenberg SB. Respiratory consequences of rhinoviruses infection. Arch Intern Med 2003; 163: 278-84.
35. Rotbart HA, Hayden FG. Picomavirus infections: a primer for the practitioner. Arch Fam Med 2000; 9: 913-20.
36. Message SD, Johnston SL. Viruses in asthma. Br Med Bull 2002; 61: 29-43.
37. Gern JE. Rhinovirus respiratory infections and asthma. Am J Med 2002; 112: 19S-27S.
38. Dearden CJ, Al-Nakib W. Direct detection of rhinoviruses by an enzyme-linked immunosorbent assay. J Med Virol 1987; 23: 179-89.
39. Arruda E, Crump CE, Rollins BS, Ohlins A, Hayden FG. Comparative susceptibilities of human embryonic fibroblasts and HeLA cells for isolation of human rhinovirus. J Clin Microbiol 1996; 34: 1277-9.
40. Kenny GE, Cooney MK, Thompson DJ. Analysis of serum pooling schemes for identification of large numbers of viruses. Am J Epidemiol 1970; 91: 439-45.
41. Hayden FG, Kaiser DL, Albrecht JK. Intranasal recombinant alfa-2b interferon treatment of naturally occuring common colds. Antimicrobial Agents Chemother 1988; 32: 224-30.
42. Hayden FG, Hipskind GJ, Woerner DH, et al. Intranasal pirodavir (R77,975) treatment of rhinovirus colds. Antimicrobial Agents Chemother 1995; 39: 290-4.
43. Abzug MJ, Cloud G, Bradley J, et al. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J 2003; 22: 335-41.